image: A group photo featuring our BGI Genomics Europe together with all our European partners.
Credit: BGI Genomics
BGI Genomics successfully convened its 2025 European Partnership & Networking Summit on December 5th at the Budapest Marriott Hotel. The event brought together key partners from across the European region for a full-day strategic forum focused on Innovation, Collaboration, and Growth. The summit served to strengthen alliances, showcase cutting-edge genomic solutions, and celebrate 15 years of BGI Genomics' presence and partnership in Europe.
The agenda was strategically designed to move beyond conventional presentations, fostering a dynamic environment of peer-to-peer learning and practical knowledge exchange. It seamlessly blended high-level technology showcases with grounded partner case studies and interactive discussions.
During the summit, BGI Genomics introduced its Gensiro, a comprehensive one-stop NGS solution that integrates AI, automation, and localization to streamline laboratory workflows. The session culminated in a deep dive into localized precision medicine laboratory solutions, focusing on practical technology transfer and accelerating diagnostic efficiency.
Sessions led by BGI Genomics and European partners further provided updates on sequencing technologies and clinical solutions. Presenting the latest innovations, including the SIRO series automation solutions and PTseq™ technology, demonstrates their role in advancing rapid molecular diagnosis, which generated strong interest for new application avenues.
The COLOTECT™ roundtable with partners from Poland (Salve Medica) and Hungary (Endorobotics) facilitated a direct exchange of best practices and hurdles in colorectal cancer screening.
A pinnacle moment was the Partner Recognition Ceremony, where BGI Genomics honored key collaborators for their shared journey and contributions to advancing genomics in Europe. This ceremony, intertwined with closing remarks and a future vision roadmap, reinforced the mutual commitment to long-term growth. A defining outcome was the significant strengthening of the partner network.
Beyond formal sessions, extensive interactions between partners and BGI Genomics teams, across sales, product, and technical functions, addressed specific queries, brainstormed ideas, and laid the groundwork for future cooperation in a highly productive atmosphere.
The gathering also served as a broader milestone celebration, marking 15 years of BGI Genomics' presence in Europe with a commemorative ceremony that honored the collective journey. Additionally, a pre-summit visit to the local Istenhegyi Géndiagnosztika laboratory offered partners an in-depth look at regional operational practices, deepening the context for the strategic discussions that followed.
The summit concluded with overwhelmingly positive feedback, with partners highlighting its practical value, energy, and strong sense of community. The enthusiasm has already translated into concrete interest for continued dialogue, signaling clear momentum for deepened regional collaboration in the year ahead.
BGI Genomics looks forward to building on this foundation, working side by side with partners to create shared value across Europe and beyond.
About BGI Genomics
BGI Genomics, headquartered in Shenzhen, China, is the world's leading integrated solutions provider of precision medicine. Its services cover more than 100 countries and regions and involve more than 2,300 medical institutions. In July 2017, as a subsidiary of BGI Group, BGI Genomics (300676.SZ) officially began trading on the Shenzhen Stock Exchange.